Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray A Raskind

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Alcohol (Fayetteville, N.Y.)|March 25, 2008
alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanolBrendan M Walker, Dennis D Rasmussen, Murray A Raskind, et al.
Journal of Geriatric Psychiatry and Neurology|September 12, 2003
Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorderElaine R Peskind, Lauren T Bonner, David J Hoff, et al.
The Journal of Clinical Psychiatry|November 8, 2024
Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress DisorderRakesh Jain, Craig Chepke, Lori L Davis, et al.
Archives of Neurology|February 18, 2004
The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trialMurray A Raskind, Elaine R Peskind, Luc Truyen, et al.
The Annals of Pharmacotherapy|September 8, 2005
Antipsychotic polypharmacy: do benefits justify the risks?Andre M Tapp, Amanda Ernst Wood, Nael Kilzieh, et al.
Neurobiology of Stress|December 2, 2014
The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress DisorderAmy F T Arnsten, Murray A Raskind, Fletcher B Taylor, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in ratsMurray A Raskind, Brianna L Burke, Norman J Crites, et al.
Chronic Stress (Thousand Oaks, Calif.)|February 24, 2021
The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related ClusteringRebecca C Hendrickson, Steven P Millard, Kathleen F Pagulayan, et al.
Journal of Traumatic Stress|August 23, 2008
Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosinCharles E Thompson, Fletcher B Taylor, Miles E McFall, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2006
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodiesPatricia Szot, Sylvia S White, J Lynne Greenup, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Alcohol (Fayetteville, N.Y.)|March 25, 2008
alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanolBrendan M Walker, Dennis D Rasmussen, Murray A Raskind, et al.
Journal of Geriatric Psychiatry and Neurology|September 12, 2003
Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorderElaine R Peskind, Lauren T Bonner, David J Hoff, et al.
The Journal of Clinical Psychiatry|November 8, 2024
Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress DisorderRakesh Jain, Craig Chepke, Lori L Davis, et al.
Archives of Neurology|February 18, 2004
The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trialMurray A Raskind, Elaine R Peskind, Luc Truyen, et al.
The Annals of Pharmacotherapy|September 8, 2005
Antipsychotic polypharmacy: do benefits justify the risks?Andre M Tapp, Amanda Ernst Wood, Nael Kilzieh, et al.
Neurobiology of Stress|December 2, 2014
The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress DisorderAmy F T Arnsten, Murray A Raskind, Fletcher B Taylor, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2006
Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in ratsMurray A Raskind, Brianna L Burke, Norman J Crites, et al.
Chronic Stress (Thousand Oaks, Calif.)|February 24, 2021
The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related ClusteringRebecca C Hendrickson, Steven P Millard, Kathleen F Pagulayan, et al.
Journal of Traumatic Stress|August 23, 2008
Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosinCharles E Thompson, Fletcher B Taylor, Miles E McFall, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2006
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodiesPatricia Szot, Sylvia S White, J Lynne Greenup, et al.
Pageof 9